NEW YORK, Aug. 18 /PRNewswire-Asia-FirstCall/ -- American Oriental
Bioengineering, Inc. (NYSE: AOB), ('the Company' or 'AOBO'), a pharmaceutical
company dedicated to improving health through the development, manufacture and
commercialization of a broad range of prescription and over the counter ('OTC')
products in China, today announced that two of AOBO's branded products, Jinji
Capsules and Boke Nasal Spray, were awarded the designation of 'China's Top
Branded Drugs of 2009' at an award ceremony held in Shanghai on August 11,
2009.
The selection process took one year to complete and, in total, 60 branded
drugs manufactured by 52 Chinese and global pharmaceutical companies were
included in the list. The assessment committee was composed of experts in the
areas of clinical work, pharmaceuticals, marketing and branding, and the
selection criteria included the drugs' quality, efficacy, health-economic
indicators, market share and brand influence.
Mr. Tony Liu, Chairman and Chief Executive Officer of American Oriental
Bioengineering, commented, 'We are very honored to receive this recognition
from industry experts. This important distinction validates our branding
strategy and adds credibility to these brands on a national basis. This award
speaks to the strength of our brand value in the competitive Chinese market,
and builds on our achievement of being named a Top 20 Most Competitive Public
Pharmaceutical Company in China, which we received in July.'
Jinji Capsule (Prescription and OTC Product)
The Jinji brand gynecological products are AOBO's flagship women's health
products. Leading Jinji products include Jinji Capsule and Jinji Yi Mu Cau.
Jinji Capsule treats various women's health issues such as gynecological
inflammation, endometritis and annexitis and is complementary to AOBO's other
product lines in the women's health marketplace. Based on government data,
there are 147 million women in China that suffer from gynecological
inflammation.
Boke Nasal Spray (OTC Product)
Boke nasal spray is an over-the-counter pharmaceutical product approved
and marketed for the treatment of sinus congestion from common cold, stuffy
nose, chronic rhinitis, allergic rhinitis and nasosinusitis. The spray is
marketed under the product name of Ditong Biyanshui Penwuji ('Ditong').
Ditong is approved by the SFDA in China and marketed as a branded drug. This
product consists of a combination of many parts of TCM plants, including roots,
vines, flowers and stems. Treatment dosage is three to four times a day and
two sprays into each nostril.
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. is a pharmaceutical company
dedicated to improving health through the development, manufacture and
commercialization of a broad range of prescription and over the counter
products in China.
Statements made in this press release are forward-looking and are made
pursuant to the safe harbor provisions of the Securities Litigation Reform Act
of 1995. Such statements involve risks and uncertainties that may cause
actual results to differ materially from those set forth in these statements.
The economic, competitive, governmental, technological and other factors
identified in the Company's filings with the Securities and Exchange
Commission, including the Form 10-K for the year ended December 31, 2008, may
cause actual results or events to differ materially from those described in
the forward looking statements in this press release. The Company undertakes
no obligation to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
For more information, please contact:
Integrated Corporate Relations, Inc.
Ashley M. Ammon
Tel: +1-203-682-8208
SOURCE American Oriental Bioengineering, Inc.
